The Latest Breaking News from Nasdaq

The FDA has issued a Complete Response Letter (CRL) to Axsome Therapeutics Inc's (NASDAQ:AXSM) AXS-07 for the acute treatment of migraine.  The CRL did not identify or raise any concerns about the clinical efficacy or safety data in the NDA, and the FDA did not request any new clinical trials to support the approval…

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) shares are trading lower by 3.42% to $263.88 during Monday’s pre-market session after the company announced VX-880 Phase 1/2 has been placed on clinical hold by the FDA due to “a determination that there is insufficient information to support do

The U.S. Food and Drug Administration (FDA) has granted orphan-drug designation to IDEAYA Biosciences (NASDAQ: IDYA) for its drug candidate Darovasertib for the treatment of uveal melanoma.

Innoviz Technologies Ltd (NASDAQ: INVZ) shares are trading higher Monday after the company announced that a large vehicle manufacturer selected Innoviz as its direct LiDAR supplier across multiple brands.

Morgan Stanley boosted Archer-Daniels-Midland Company (NYSE: ADM) price target from $69 to $94. Archer-Daniels-Midland shares fell 0.5% to $89.10 in pre-market trading.

Ceragon Networks Ltd (NASDAQ:CRNT) reported first-quarter FY22 revenue growth of 2.9% year-on-year to $70.3 million, missing the consensus of $71.2 million. Ceragon saw strong bookings in North America, India, Europe, and LATAM, with a trailing 12 months book-to-bill above 1. In North America, Ceragon acquired five new G customers, including DISH Network Corp (NASDAQ:DISH) and private…

Biotech stocks posted weekly declines yet again in the week ending April 29, taking cues from the weak broader market sentiment. Big pharma earnings, clinical readouts and pipeline updates moved stocks during the week.

Akanda Corp.